Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2- <i>a</i> ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity-Reference-Cited by-同舟云学术

Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity

Published:2023-05-11 Issue:1 Volume:38 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Mourad Mai A. E.¹^ORCID,Abo Elmaaty Ayman¹,Zaki Islam²,Mourad Ahmed A. E.³^ORCID,Hofni Amal⁴,Khodir Ahmed E.⁵,Aboubakr Esam M.⁴,Elkamhawy Ahmed⁶⁷,Roh Eun Joo⁸⁹,Al-Karmalawy Ahmed A.¹⁰^ORCID

Affiliation:

1. Medicinal Chemistry Department, Faculty of Pharmacy, Port-Said University, Port-Said, Egypt

2. Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Port-Said University, Port-Said, Egypt

3. Pharmacology and Toxicology Department, Faculty of Pharmacy, Port-Said University, Port-Said, Egypt

4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena, Egypt

5. Department of Pharmacology, Faculty of Pharmacy, Horus University, New Damietta, Egypt

6. BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University—Seoul, Goyang, Republic of Korea

7. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

8. Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology (KIST), Seoul, Korea

9. Division of Bio-Medical Science & Technology, University of Science and Technology, Daejeon, Korea

10. Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Giza, Egypt

Funder

KIST Institutional programs

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2205043

Reference59 articles.

1. Nanooncology: The future of cancer diagnosis and therapy

2. From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage

3. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids

4. Topoisomerases as anticancer targets;Justine L;Biochem. J,2018

5. Origin and evolution of DNA topoisomerases

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Exploration of Novel EGFR Kinase Mutant-Selective Inhibitors Using a Hybrid Computational Approach;Pharmaceuticals;2024-08-23

2. Organoselenium-based Azomethines as Apoptosis Inducers in Colorectal Carcinoma via P53, BAX, Caspase-3, Caspase-6, and Caspase-9 Modulations;Current Medicinal Chemistry;2024-08-12

3. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study;Bioorganic Chemistry;2024-07

4. In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety;Future Medicinal Chemistry;2024-07

5. Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators;Archiv der Pharmazie;2024-06-12